Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-032222
Filing Date
2021-08-09
Accepted
2021-08-09 19:37:09
Documents
1
Period of Report
2021-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5449
  Complete submission text file 0000899243-21-032222.txt   7052
Mailing Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010 (212) 551-1600
DA32 Life Science Tech Acquisition Corp. (Issuer) CIK: 0001863294 (see all company filings)

EIN.: 863352988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010 (212) 551-1600
DA32 Sponsor LLC (Reporting) CIK: 0001871990 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40676 | Film No.: 211157970